The direct release of dialkylanilines
was achieved by controlling
the outcome of a photorearrangement reaction promoted by the (8-cyano-7-hydroxyquinolin-2-yl)methyl
(CyHQ) photoremovable protecting group. The substrate scope was investigated
to obtain structure–activity relationships and to propose a
reaction mechanism. Introducing a methyl substituent at the 2-methyl
position of the CyHQ core enabled the bypass of the photorearrangement
and significantly improved the aniline release efficiency. We successfully
applied the strategy to the photoactivation of mifepristone (RU-486),
an antiprogestin drug that is also used to induce the LexPR gene expression
system in zebrafish and the gene-switch regulatory system based on
the pGL-VP chimeric regulator in mammals.